Hydroxyurea is a chemotherapeutic agent primarily used to treat certain types of cancer, such as chronic myeloid leukemia (CML) and head and neck cancers. It is also used to manage sickle cell disease (SCD). The drug works by inhibiting ribonucleotide reductase, an enzyme crucial for DNA synthesis, thus slowing the growth of rapidly dividing cells.
